<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04153994</url>
  </required_header>
  <id_info>
    <org_study_id>52852</org_study_id>
    <nct_id>NCT04153994</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane Blockade in Pediatric Scoliosis Surgery Patients</brief_title>
  <official_title>Pediatric Scoliosis Surgery: Enhanced Recovery With Erector Spinae Plane Blockade Utilizing Surgically Placed Catheters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Providing effective analgesia after spinal fusion for idiopathic scoliosis remains a
      challenge with significant practice variation existing among high volume spine surgery
      centers. Even in the era of multimodal analgesia, opioids are the primary analgesics used for
      pain control after pediatric scoliosis surgery, but have multiple known adverse effects. The
      erector spinae plane block (ESPB) is a newly described fascial plane block performed by
      injecting local anesthetic between the erector spinae muscle and the transverse process.
      Additionally, there are case reports describing the ESPB as part of a multi-modal analgesic
      plan in adult degenerative spine surgery as well as adult spinal deformity surgery,
      demonstrating effective analgesia and no clinical motor blockade. Although it is known that
      the inflammatory reaction plays a crucial role in the mechanism of acute pain after major
      surgery, the effectiveness of the current regional approach on inflammatory response is not
      well studied.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Stay (LOS)</measure>
    <time_frame>Through hospital stay, an average of 5 days</time_frame>
    <description>Determine if bilateral surgical placed ESPBs will decrease length of stay in the pediatric ICU and the hospital. LOS and decrease postoperative opioid consumption.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Opioid Consumption</measure>
    <time_frame>Through hospital stay, an average of 5 days</time_frame>
    <description>Determine if bilateral surgical placed ESPBs will decrease postoperative opioid consumption measured in Morphine Milligram Equivalents (MME)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Understand clinical pharmacodynamics and pharmacokinetics of ESPBs</measure>
    <time_frame>Through hospital stay, an average of 5 days</time_frame>
    <description>Serial plasma lidocaine levels will be tracked daily to examine systemic absorption from ESPB catheters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Pain Scores</measure>
    <time_frame>Through hospital stay, an average of 5 days</time_frame>
    <description>Patients will be asked on a daily basis by the research staff to report pain scores to evaluate the effectiveness of the interventions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inpatient Postoperative Mobility</measure>
    <time_frame>Through hospital stay, an average of 5 days</time_frame>
    <description>Inpatient postoperative mobility will be tracked using activity tracker accelerometers and subsequently compared between the two groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Through hospital stay, an average of 5 days</time_frame>
    <description>Patients will be tracked post-operatively to assess for any adverse events requiring deviation from study protocol associated with ESPB catheter placement.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Scoliosis; Juvenile</condition>
  <condition>Scoliosis; Adolescence</condition>
  <arm_group>
    <arm_group_label>Erector Spinae Plane Blockade Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive an erector spinae plane blockade prior to their surgery as per standard regional anesthesia technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erector Spinae Plane Blockade Control - Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive the standard of care for pediatric scoliosis surgery including multi-modal opioid pain management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector Spinae Plane Blockade</intervention_name>
    <description>The ESPB is fascial plane block performed by injecting local anesthetic between the erector spinae muscle and the transverse process. Its proposed mechanism of action is via blockade of the dorsal and ventral rami of the thoracic spinal nerves and sympathetic fibers.</description>
    <arm_group_label>Erector Spinae Plane Blockade Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  Diagnosed with Idiopathic scoliosis

          -  Undergoing single-stage posterior spinal instrumentation and fusion

        Exclusion Criteria:

          -  Thorascopic tethering procedure

          -  Two-stage procedure

          -  Abnormal developmental profile

          -  Congenital/neuromuscular scoliosis

          -  Requiring PICU admission

          -  Known allergy to lidocaine

          -  Known cardiac, renal or liver disease or dysfunction

          -  Pre-existing pain complaints, i.e. on regular analgesic medications

          -  Current psychiatric diagnosis, e.g. anxiety, depression, eating disorder, defined
             according to DSM criteria.

          -  Requiring non-standard post-op pain management

          -  Any history of seizures

          -  Unplanned staged procedure

          -  Weight &lt; 5th centile or &gt; 85th centile for age

          -  Porphyria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ban Tsui, MD</last_name>
    <phone>(650)200-9107</phone>
    <email>bantsui@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aaron Deng, BS</last_name>
    <email>adeng1@stanford.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002 Jun;3(3):159-80.</citation>
    <PMID>14622770</PMID>
  </reference>
  <reference>
    <citation>Sheffer BW, Kelly DM, Rhodes LN, Sawyer JR. Perioperative Pain Management in Pediatric Spine Surgery. Orthop Clin North Am. 2017 Oct;48(4):481-486. doi: 10.1016/j.ocl.2017.06.004. Epub 2017 Jul 15. Review.</citation>
    <PMID>28870307</PMID>
  </reference>
  <reference>
    <citation>Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.</citation>
    <PMID>27501016</PMID>
  </reference>
  <reference>
    <citation>Kose HC, Kose SG, Thomas DT. Lumbar versus thoracic erector spinae plane block: Similar nomenclature, different mechanism of action. J Clin Anesth. 2018 Aug;48:1. doi: 10.1016/j.jclinane.2018.03.026. Epub 2018 Apr 9.</citation>
    <PMID>29649625</PMID>
  </reference>
  <reference>
    <citation>Almeida CR, Oliveira AR, Cunha P. Continuous Bilateral Erector of Spine Plane Block at T8 for Extensive Lumbar Spine Fusion Surgery: Case Report. Pain Pract. 2019 Jun;19(5):536-540. doi: 10.1111/papr.12774. Epub 2019 Mar 15.</citation>
    <PMID>30758122</PMID>
  </reference>
  <reference>
    <citation>Kline J, Chin KJ. Modified dual-injection lumbar erector spine plane (ESP) block for opioid-free anesthesia in multilevel lumbar laminectomy. Korean J Anesthesiol. 2019 Apr;72(2):188-190. doi: 10.4097/kja.d.18.00289. Epub 2018 Nov 2.</citation>
    <PMID>30392347</PMID>
  </reference>
  <reference>
    <citation>Melvin JP, Schrot RJ, Chu GM, Chin KJ. Low thoracic erector spinae plane block for perioperative analgesia in lumbosacral spine surgery: a case series. Can J Anaesth. 2018 Sep;65(9):1057-1065. doi: 10.1007/s12630-018-1145-8. Epub 2018 Apr 27.</citation>
    <PMID>29704223</PMID>
  </reference>
  <reference>
    <citation>Demmy TL, Nwogu C, Solan P, Yendamuri S, Wilding G, DeLeon O. Chest tube-delivered bupivacaine improves pain and decreases opioid use after thoracoscopy. Ann Thorac Surg. 2009 Apr;87(4):1040-6; discussion 1046-7. doi: 10.1016/j.athoracsur.2008.12.099.</citation>
    <PMID>19324125</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 24, 2019</study_first_submitted>
  <study_first_submitted_qc>November 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Chi-Ho Ban Tsui</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Erector Spinae Plane Blockade</keyword>
  <keyword>Pediatric Scoliosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

